← FDA DRUG APPROVALS

FDA ANDA · ANDA074330

VERAPAMIL HYDROCHLORIDE

Sponsor: IVAX SUB TEVA PHARMS

APPLICATION
ANDA074330
TYPE
ANDA
ORIGINAL APPROVAL
1994-01-31
LATEST ACTION
2012-03-30
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

VERAPAMIL HYDROCHLORIDEDiscontinued
VERAPAMIL HYDROCHLORIDE 180MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2012-03-30Labeling · Supplement 38AP
2010-04-28Labeling · Supplement 36AP
2009-09-18Labeling · Supplement 32AP
2007-04-12Manufacturing (CMC) · Supplement 27AP
2002-09-05Manufacturing (CMC) · Supplement 23AP
2002-03-26Manufacturing (CMC) · Supplement 22AP
2001-09-12Manufacturing (CMC) · Supplement 21AP
2001-06-07Manufacturing (CMC) · Supplement 14AP
2001-03-21Manufacturing (CMC) · Supplement 20AP
2001-02-06Manufacturing (CMC) · Supplement 18AP
2000-11-28Manufacturing (CMC) · Supplement 17AP
2000-10-06Manufacturing (CMC) · Supplement 13AP
2000-10-06Manufacturing (CMC) · Supplement 11AP
2000-10-06Labeling · Supplement 16AP
2000-08-10Manufacturing (CMC) · Supplement 19AP
2000-08-10Manufacturing (CMC) · Supplement 15AP
2000-06-28Manufacturing (CMC) · Supplement 12AP
1999-07-22Manufacturing (CMC) · Supplement 10AP
1999-07-01Manufacturing (CMC) · Supplement 9AP
1998-10-06Manufacturing (CMC) · Supplement 8AP
1996-04-26Manufacturing (CMC) · Supplement 4AP
1996-04-26Manufacturing (CMC) · Supplement 2AP
1996-04-26Manufacturing (CMC) · Supplement 3AP
1994-01-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →